Literature DB >> 18513966

1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: a novel series of highly potent revertants of P-glycoprotein associated multidrug resistance.

Umashankar Das1, Joseph Molnár, Zoltán Baráth, Zsuzsanna Bata, Jonathan R Dimmock.   

Abstract

The 1-[4-(2-aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines 5-8 are a novel cluster of highly potent P-glycoprotein dependent multidrug resistance (MDR) revertants. Using a concentration of 4mug/mL, these compounds possess 11-43 times the potency of verapamil in reversing MDR in murine L-5178 lymphoma cells transfected with the human MDR1 gene. Structure-activity relationships reveal that the attachment of the N-aroyl group to various 3,5-bis(benzylidene)-4-piperidones is essential for MDR reversal to occur. In terms of potencies, the 1-piperidinyl group is the preferred terminal amine while the 4-methyl and 4-chloro substituents are the optimal groups for placement in the benzylidene aryl rings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513966      PMCID: PMC3310923          DOI: 10.1016/j.bmcl.2008.05.034

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  24 in total

Review 1.  Multidrug resistance reversal agents.

Authors:  Jacques Robert; Christian Jarry
Journal:  J Med Chem       Date:  2003-11-06       Impact factor: 7.446

2.  Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.

Authors:  C Pauli-Magnus; O von Richter; O Burk; A Ziegler; T Mettang; M Eichelbaum; M F Fromm
Journal:  J Pharmacol Exp Ther       Date:  2000-05       Impact factor: 4.030

Review 3.  ABC transporters and inhibitors: new targets, new agents.

Authors:  Gregory D Leonard; Orsolya Polgar; Susan E Bates
Journal:  Curr Opin Investig Drugs       Date:  2002-11

4.  Amiodarone-induced enhancement of doxorubicin and 4'-deoxydoxorubicin cytotoxicity to rat colon cancer cells in vitro and in vivo.

Authors:  B Chauffert; M Martin; A Hammann; M F Michel; F Martin
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

5.  P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells.

Authors:  Y Chen; A C Pant; S M Simon
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

6.  MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping.

Authors:  A J Smith; A van Helvoort; G van Meer; K Szabo; E Welker; G Szakacs; A Varadi; B Sarkadi; P Borst
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

7.  3,5-dibenzoyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells.

Authors:  Masami Kawase; Anamik Shah; Harsukh Gaveriya; Noboru Motohashi; Hiroshi Sakagami; Andreas Varga; Joseph Molnár
Journal:  Bioorg Med Chem       Date:  2002-04       Impact factor: 3.641

8.  N-Aroyl-3,5-bis(benzylidene)-4-piperidones: a novel class of antimycobacterial agents.

Authors:  Umashankar Das; Swagatika Das; Brian Bandy; James P Stables; Jonathan R Dimmock
Journal:  Bioorg Med Chem       Date:  2008-02-08       Impact factor: 3.641

9.  Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.

Authors:  Liwu Fu; Yongju Liang; Liwen Deng; Yan Ding; Liming Chen; Yanli Ye; Xiaoping Yang; Qichao Pan
Journal:  Cancer Chemother Pharmacol       Date:  2003-12-10       Impact factor: 3.333

10.  Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids.

Authors:  Pornngarm Limtrakul; Songyot Anuchapreeda; Duang Buddhasukh
Journal:  BMC Cancer       Date:  2004-04-17       Impact factor: 4.430

View more
  4 in total

1.  CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.

Authors:  Pallavi Lagisetty; Prachi Vilekar; Kaustuv Sahoo; Shrikant Anant; Vibhudutta Awasthi
Journal:  Bioorg Med Chem       Date:  2010-06-22       Impact factor: 3.641

Review 2.  1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets.

Authors:  U Das; R K Sharma; J R Dimmock
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

3.  2-(3-Aryl-2-propenoyl)-3-methylquinoxaline-1,4-dioxides: a novel cluster of tumor-specific cytotoxins which reverse multidrug resistance.

Authors:  Umashankar Das; Hari N Pati; Atulya K Panda; Erik De Clercq; Jan Balzarini; Joseph Molnár; Zoltán Baráth; Imre Ocsovszki; Masami Kawase; Li Zhou; Hiroshi Sakagami; Jonathan R Dimmock
Journal:  Bioorg Med Chem       Date:  2009-04-17       Impact factor: 3.641

4.  3,5-Bis(benzylidene)-4-oxo-1-phosphonopiperidines and related diethyl esters: Potent cytotoxins with multi-drug-resistance reverting properties.

Authors:  Swagatika Das; Umashankar Das; Ponniah Selvakumar; Rajendra K Sharma; Jan Balzarini; Erik De Clercq; Joseph Molnár; Julianna Serly; Zoltán Baráth; Gabriele Schatte; Brian Bandy; Dennis K J Gorecki; Jonathan R Dimmock
Journal:  ChemMedChem       Date:  2009-11       Impact factor: 3.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.